{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T03:19:22Z","timestamp":1793848762395,"version":"4.6.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,1,13]],"date-time":"2020-01-13T00:00:00Z","timestamp":1578873600000},"content-version":"vor","delay-in-days":1565,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100006383","name":"Cancer Society of Finland","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006383","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100008376","name":"Helsinki University Central Hospital","doi-asserted-by":"crossref","award":["T10200066"],"award-info":[{"award-number":["T10200066"]}],"id":[{"id":"10.13039\/100008376","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jpsmjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pain and Symptom Management"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jpainsymman.2014.09.004","type":"journal-article","created":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T12:39:18Z","timestamp":1411130358000},"page":"524-532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Opioid Concentrations in Oral Fluid and Plasma in Cancer Patients With Pain"],"prefix":"10.1016","volume":"50","author":[{"given":"Tarja","family":"Heiskanen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaarina","family":"Langel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teemu","family":"Gunnar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pirjo","family":"Lillsunde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eija A.","family":"Kalso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpainsymman.2014.09.004_bib1","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/j.ejpain.2008.11.006","article-title":"Trends in opioid consumption in the Nordic countries 2002-2006","volume":"13","author":"Hamunen","year":"2009","journal-title":"Eur J Pain"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/pds.1878","article-title":"Usefulness of prescription monitoring programs for surveillance\u2014analysis of schedule II opioid prescription data in Massachusetts, 1996-2006","volume":"19","author":"Katz","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pain.2010.07.031","article-title":"NeuPSIG guidelines on neuropathic pain assessment","volume":"152","author":"Haanpaa","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00228-010-0948-5","article-title":"Influences on the pharmacokinetics of oxycodone: a multicentre cross-sectional study in 439 adult cancer patients","volume":"67","author":"Andreassen","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jpainsymman.2004.04.015","article-title":"Efficacy, safety, and steady-state pharmacokinetics of once-a-day controlled-release morphine (MS Contin XL) in cancer pain","volume":"29","author":"Hagen","year":"2005","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0376-8716(97)00070-7","article-title":"A\u00a0comparison of blood toxicology of heroin-related deaths and current heroin users in Sydney, Australia","volume":"47","author":"Darke","year":"1997","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib7","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1556-4029.2011.01703.x","article-title":"Toxicology and characteristics of fatal oxycodone toxicity cases in New South Wales, Australia 1999-2008","volume":"56","author":"Darke","year":"2011","journal-title":"J\u00a0Forensic Sci"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib8","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1080\/02841860050215927","article-title":"Morphine or oxycodone in cancer pain?","volume":"39","author":"Heiskanen","year":"2000","journal-title":"Acta Oncol"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib9","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/ALN.0b013e31819faa54","article-title":"Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodone","volume":"110","author":"Nieminen","year":"2009","journal-title":"Anesthesiology"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib10","first-page":"1","article-title":"Analysis of drugs of abuse in saliva","volume":"11","author":"Samyn","year":"1999","journal-title":"Forensic Sci Rev"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib11","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.forsciint.2011.05.012","article-title":"The incidence of drugs of impairment in oral fluid from random roadside testing","volume":"215","author":"Chu","year":"2012","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib12","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1373\/clinchem.2008.108670","article-title":"Oral fluid testing for drugs of abuse","volume":"55","author":"Bosker","year":"2009","journal-title":"Clin Chem"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib13","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.drugalcdep.2006.08.020","article-title":"Oral fluid as an alternative matrix to monitor opiate and cocaine use in substance-abuse treatment patients","volume":"87","author":"Dams","year":"2007","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib14","first-page":"54","article-title":"Salivary phenytoin concentrations in geriatric patients","volume":"1","author":"Umstead","year":"1982","journal-title":"Clin Pharm"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib15","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1542\/peds.80.6.894","article-title":"Monitoring theophylline therapy using citric acid-stimulated saliva in infants and children with asthma","volume":"80","author":"Aviram","year":"1987","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib16","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/dta.1532","article-title":"Comparison of drug concentrations between whole blood and oral fluid","volume":"6","author":"Langel","year":"2014","journal-title":"Drug Test Anal"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib17","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/clinchem\/48.9.1486","article-title":"Plasma and oral fluid pharmacokinetics and pharmacodynamics after oral codeine administration","volume":"48","author":"Kim","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib18","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1097\/00007691-199710000-00008","article-title":"Correlation of morphine sulfate in blood plasma and saliva in pediatric patients","volume":"19","author":"Kopecky","year":"1997","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib19","first-page":"767","article-title":"Is saliva a valid substitute for plasma in pharmacokinetic studies of oxycodone and its metabolites in patients with cancer?","volume":"20","author":"Hardy","year":"2012","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib20","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jchromb.2011.02.027","article-title":"A\u00a0validated method for the detection and quantitation of 50 drugs of abuse and medicinal drugs in oral fluid by gas chromatography-mass spectrometry","volume":"879","author":"Langel","year":"2011","journal-title":"J\u00a0Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib21","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/jms.846","article-title":"Validated toxicological determination of 30 drugs of abuse as optimized derivatives in oral fluid by long column fast gas chromatography\/electron impact mass spectrometry","volume":"40","author":"Gunnar","year":"2005","journal-title":"J\u00a0Mass Spectrom"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib22","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.forsciint.2006.05.021","article-title":"Validation of new methods","volume":"165","author":"Peters","year":"2007","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib23","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/FTD.0b013e3181ae46ea","article-title":"Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs","volume":"31","author":"Wille","year":"2009","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1749-6632.1993.tb18346.x","article-title":"Saliva testing for drugs of abuse","volume":"694","author":"Cone","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.5055\/jom.2012.0112","article-title":"Interpretation of oxycodone concentrations in oral fluid","volume":"8","author":"Moore","year":"2012","journal-title":"J\u00a0Opioid Manag"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib26","first-page":"451","article-title":"Oxycodone. Pharmacological profile and clinical data in chronic pain management","volume":"71","author":"Coluzzi","year":"2005","journal-title":"Minerva Anestesiol"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib27","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1023\/A:1015932610010","article-title":"Solubility behavior of narcotic analgesics in aqueous media: solubilities and dissociation constants of morphine, fentanyl, and sufentanil","volume":"6","author":"Roy","year":"1989","journal-title":"Pharm Res"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib28","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1053\/j.jvca.2004.11.039","article-title":"pKa of fentanyl varies with temperature: implications for acid-base management during extremes of body temperature","volume":"19","author":"Thurlkill","year":"2005","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1600-0773.1994.tb01068.x","article-title":"Liposolubility and protein binding of oxycodone in\u00a0vitro","volume":"74","author":"Poyhia","year":"1994","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib30","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.clpt.2003.08.011","article-title":"Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine","volume":"74","author":"Kharasch","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib31","doi-asserted-by":"crossref","first-page":"4928","DOI":"10.1002\/jps.21770","article-title":"Differential involvement of P-glycoprotein (ABCB1) in permeability, tissue distribution, and antinociceptive activity of methadone, buprenorphine, and diprenorphine: in\u00a0vitro and in\u00a0vivo evaluation","volume":"98","author":"Hassan","year":"2009","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib32","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1002\/jps.20893","article-title":"Oxycodone induces overexpression of P-glycoprotein (ABCB1) and affects paclitaxel's tissue distribution in sprague dawley rats","volume":"96","author":"Hassan","year":"2007","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib33","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/jps.20327","article-title":"Oxycodone pharmacokinetics and pharmacodynamics in the rat in the presence of the P-glycoprotein inhibitor PSC833","volume":"94","author":"Bostr\u00f6m","year":"2005","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib34","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1124\/dmd.108.022087","article-title":"Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone","volume":"36","author":"Okura","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib35","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1124\/dmd.106.009746","article-title":"In\u00a0vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics\/pharmacodynamics","volume":"34","author":"Bostr\u00f6m","year":"2006","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1191\/026921601673324846","article-title":"A\u00a0prospective survey of the use of dexamethasone on a palliative care unit","volume":"15","author":"Hardy","year":"2001","journal-title":"Palliat Med"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/00007691-198208000-00001","article-title":"The use of saliva in therapeutic drug monitoring","volume":"4","author":"Mucklow","year":"1982","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib38","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/jat\/32.6.393","article-title":"Drug testing in oral fluid-evaluation of sample collection devices","volume":"32","author":"Langel","year":"2008","journal-title":"J\u00a0Anal Toxicol"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib39","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/jat\/27.7.449","article-title":"The determination of morphine in urine and oral fluid following ingestion of poppy seeds","volume":"27","author":"Rohrig","year":"2003","journal-title":"J\u00a0Anal Toxicol"},{"key":"10.1016\/j.jpainsymman.2014.09.004_bib40","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/jat\/29.1.22","article-title":"Screening for drugs of abuse in oral fluid\u2014correlation of analysis results with serum in forensic cases","volume":"29","author":"Toennes","year":"2005","journal-title":"J\u00a0Anal Toxicol"}],"container-title":["Journal of Pain and Symptom Management"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392414004679?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0885392414004679?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:15:23Z","timestamp":1760130923000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0885392414004679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S0885392414004679"],"URL":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2014.09.004","relation":{},"ISSN":["0885-3924"],"issn-type":[{"value":"0885-3924","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioid Concentrations in Oral Fluid and Plasma in Cancer Patients With Pain","name":"articletitle","label":"Article Title"},{"value":"Journal of Pain and Symptom Management","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpainsymman.2014.09.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}